Centene Corporation (CNC) Director Robert K. Ditmore Sells 8,750 Shares

Centene Corporation (NYSE:CNC) Director Robert K. Ditmore sold 8,750 shares of Centene stock in a transaction dated Monday, January 8th. The shares were sold at an average price of $104.30, for a total value of $912,625.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Robert K. Ditmore also recently made the following trade(s):

  • On Thursday, October 26th, Robert K. Ditmore sold 4,167 shares of Centene stock. The shares were sold at an average price of $90.42, for a total value of $376,780.14.

Shares of Centene Corporation (NYSE:CNC) opened at $106.78 on Friday. Centene Corporation has a 12 month low of $61.15 and a 12 month high of $106.80. The company has a market capitalization of $18,430.00, a PE ratio of 22.06, a PEG ratio of 1.32 and a beta of 0.70. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.99 and a current ratio of 0.99.

Centene (NYSE:CNC) last announced its quarterly earnings results on Tuesday, October 24th. The company reported $1.35 EPS for the quarter, beating the Zacks’ consensus estimate of $1.24 by $0.11. Centene had a return on equity of 14.79% and a net margin of 1.81%. The firm had revenue of $11.90 billion for the quarter, compared to analyst estimates of $11.75 billion. During the same period last year, the firm posted $1.12 earnings per share. The business’s revenue for the quarter was up 9.7% on a year-over-year basis. sell-side analysts anticipate that Centene Corporation will post 4.99 EPS for the current fiscal year.

A number of research analysts have issued reports on the company. Cowen reiterated a “buy” rating and issued a $115.00 target price on shares of Centene in a research report on Tuesday, October 24th. Piper Jaffray Companies reiterated a “buy” rating and issued a $134.00 target price on shares of Centene in a research report on Monday, December 18th. Jefferies Group lifted their target price on Centene from $112.00 to $115.00 and gave the company a “buy” rating in a research report on Monday, December 18th. Goldman Sachs Group assumed coverage on Centene in a research report on Wednesday, January 3rd. They issued a “buy” rating and a $135.00 target price on the stock. Finally, Oppenheimer reiterated a “buy” rating and issued a $105.00 target price on shares of Centene in a research report on Tuesday, October 24th. One research analyst has rated the stock with a sell rating, three have given a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the company’s stock. Centene presently has an average rating of “Buy” and an average target price of $104.21.

Several institutional investors have recently bought and sold shares of the stock. DnB Asset Management AS lifted its stake in shares of Centene by 20.4% in the fourth quarter. DnB Asset Management AS now owns 17,100 shares of the company’s stock worth $1,725,000 after acquiring an additional 2,900 shares during the period. Atlantic Trust Group LLC acquired a new position in shares of Centene in the third quarter worth approximately $1,843,000. Parametric Portfolio Associates LLC lifted its stake in shares of Centene by 5.1% in the third quarter. Parametric Portfolio Associates LLC now owns 601,373 shares of the company’s stock worth $58,195,000 after acquiring an additional 28,979 shares during the period. Shelton Capital Management acquired a new position in shares of Centene in the third quarter worth approximately $928,000. Finally, Optimum Investment Advisors acquired a new position in shares of Centene in the third quarter worth approximately $247,000. 91.84% of the stock is currently owned by institutional investors.

ILLEGAL ACTIVITY NOTICE: “Centene Corporation (CNC) Director Robert K. Ditmore Sells 8,750 Shares” was first published by BBNS and is the sole property of of BBNS. If you are accessing this piece of content on another site, it was copied illegally and reposted in violation of US and international copyright and trademark law. The original version of this piece of content can be viewed at https://baseballnewssource.com/markets/centene-corporation-cnc-director-robert-k-ditmore-sells-8750-shares/1826029.html.

About Centene

Centene Corporation is a healthcare company. The Company provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. The Company operates through two segments: Managed Care and Specialty Services. The Company’s Managed Care segment provides health plan coverage to individuals, through government subsidized programs, including Medicaid, the State Children’s Health Insurance Program (CHIP), Long Term Care, Foster Care, dual-eligible individuals (Duals) and the Supplemental Security Income Program, also known as the Aged, Blind or Disabled Program (ABD), Medicare, and Health Insurance Marketplace.

Insider Buying and Selling by Quarter for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with our FREE daily email newsletter.

 


Latest News

Sources: Mets Bringing Back Jay Bruce with Three-Year Deal
Sources: Mets Bringing Back Jay Bruce with Three-Year Deal
Justin Morneau Former Star With Twins and AL MVP Retires
Justin Morneau Former Star With Twins and AL MVP Retires
MLB Rumor: Pirates Discussing Andrew McCutchen with Mets
MLB Rumor: Pirates Discussing Andrew McCutchen with Mets
Trade Rumor: Manny Machado Could Land With Yankees
Trade Rumor: Manny Machado Could Land With Yankees
Los Angeles Dodgers Acquire Scott Alexander as Part of Three Team Deal
Los Angeles Dodgers Acquire Scott Alexander as Part of Three Team Deal
Rumor: Braves Show Interest in Reamluto, Yelich
Rumor: Braves Show Interest in Reamluto, Yelich


Leave a Reply

 
© 2006-2018 BBNS.